Deccan HeraldITNewspapers

Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, Japan

Isha Sharma
By Isha Sharma

The US health regulator has accepted the company’s Biologics License Application (BLA) for Bmab 1200 for review.

Read more

You may also like

Comments are closed.

More in Deccan Herald